BioSpace News Archive

Pharm Country

ImageFIRST Launches New Comfort Care® Maternity Gown for New and Expecting Mothers

A portion of proceeds from gown rentals will be donated to the National Pediatric Cancer Foundation

September 9, 2019
·
4 min read
Business

Ayala Pharmaceuticals Announces Appointment of Gary Gordon, M.D., Ph.D., as Chief Medical Officer

Ayala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers, today announced the appointment of Gary Gordon, M.D., Ph.D., as its Chief Medical Officer.

September 9, 2019
·
2 min read
Global Non-Invasive Glucose Monitoring Devices Market 2019-2023 | 11% CAGR Projection Over the Next Five Years | Technavio

The global non-invasive glucose monitoring devices market size is poised to grow by USD 14.01 million during 2019-2023, according to a new report by Technavio, progressing at a CAGR of over 11% during the forecast period.

September 9, 2019
·
4 min read
Business

Rite Aid to Release Second Quarter Results on September 26

Rite Aid Corporation said that it will release financial results for its Fiscal 2020 Second Quarter, which ended Aug. 31, 2019, on Thursday, Sept. 26, 2019.

September 9, 2019
·
1 min read
Ministry of Health of Rwanda, Society for Family Health Rwanda and Abbott Launch Pioneering Model of Primary Health Care Service Delivery in Rwanda

The Ministry of Health of Rwanda, the non-profit organization Society for Family Health Rwanda and global healthcare company Abbott (NYSE: ABT) are today announcing the grand opening of a second-generation health post in Gikundamvura Cell, Ruhuha Sector, Bugesera District.

September 9, 2019
·
4 min read
Policy

Acceleron Receives FDA Orphan Drug Designation for Sotatercept in Pulmonary Arterial Hypertension

Acceleron Pharma Inc announced that the United States Food and Drug Administration has granted Orphan Drug designation to sotatercept for the treatment of patients with pulmonary arterial hypertension.

September 9, 2019
·
5 min read
Pharm Country

More Emerging Biopharma and CROs Adopting Veeva Vault CDMS

Companies are modernizing clinical data management to build studies faster and improve efficiency across clinical teams

September 9, 2019
·
5 min read
Drug Development

IMFINZI Is First Immunotherapy to Show Both Significant Survival Benefit and Improved, Durable Responses in Extensive-Stage Small Cell Lung Cancer

In the Phase III CASPIAN trial IMFINZI at a fixed, convenient dose improved survival with either a cisplatin or carboplatin chemotherapy backbone

September 9, 2019
·
18 min read
Business

Mogrify appoints Dr. Jane Osbourn, OBE as Chair

Mogrify Ltd announced the appointment of Dr. Jane Osbourn, OBE as Chair of the Board.

September 9, 2019
·
2 min read
Drug Development

Allergan and Molecular Partners Announce Acceptance of U.S. FDA Biologics License Application and Validation of EMA Marketing Authorisation for Abicipar pegol in Patients with Neovascular (Wet) Age-related Macular Degeneration

Allergan plc (NYSE: AGN), a leading global pharmaceutical company with a heritage of more than 70 years in eye care, and Molecular Partners (SIX: MOLN), a clinical-stage biotechnology company developing a new class of drugs known as DARPin® platform, today announced that the U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) and the European Medicines Agency (EMA) has validated a Marketing Authorisation Application (MAA) for Abicipar pegol,

September 9, 2019
·
7 min read